Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.
Press releases published on April 25, 2025
Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Awards 2025
EIN Presswire
·
April 25, 2025
Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Summit …
Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
GlobeNewswire
·
April 25, 2025
TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a …
Eco-Friendly Plasticizers Market worth $7.55 billion by 2030, at 7.0%, says MarketsandMarkets™
GlobeNewswire
·
April 25, 2025
Delray Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Eco-Friendly Plasticizers Market is projected to reach USD 7.55 billion by 2030 from USD 5.03 billion in 2024, at a CAGR of 7.0%, as per the recent study by MarketsandMarkets™. …
Enviri Corporation to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 25, 2025
PHILADELPHIA, April 25, 2025 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial and specialty waste streams, today announced that Company management will be participating in the …
Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”
GlobeNewswire
·
April 25, 2025
DURHAM, N.C., April 25, 2025 (GLOBE NEWSWIRE) -- Codetta Bio is proud to announce the official launch of the Concerto™ System, a revolutionary new multi-omics platform, at the American Association for Cancer Research (AACR) Annual Meeting 2025. The …
Esperion to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 25, 2025
ANN ARBOR, Mich., April 25, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted Citizens Life Sciences Conference on May 8, 2025, at 12:30 p.m. ET. The live webcast can be accessed on the …
Spiritual Essay Collection THE WALK Inspires Christians to Seek Opportunities to Be Kind
GlobeNewswire
·
April 25, 2025
Charleston, SC, April 25, 2025 (GLOBE NEWSWIRE) -- As a young boy, James H. Whittaker was taught that it takes more effort to be mean than to be kind, and the lesson resonated with him to an old age. In fact, kindness has played a central role in his life, …
LGI Homes Opens New Section at Popular Second Creek Farm Community in Commerce City, CO
GlobeNewswire
·
April 25, 2025
COMMERCE CITY, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) announced the opening of a new section at Second Creek Farm, a premier community located in Commerce City, Colorado. This expanded section of 240 lots offers homebuyers …
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2025 and Declaration of Distributions on Common Stock for the Months Ending July 31, August 31, and September 30, 2025
GlobeNewswire
·
April 25, 2025
GREENWICH, Conn., April 25, 2025 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended …
VYNE Therapeutics Provides Update on VYN202 Program
GlobeNewswire
·
April 25, 2025
BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company that it placed a clinical hold on the …
Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
Presentation to highlight how AP3 Generative Phosphoproteomic analyses uncover how ACR-2316 induces mitotic and replicative tumor cell death, and the mechanisms underlying its superior potency observed preclinically Phase 1 trial of ACR-2316 ahead of …
Access Meets Impact at NJIT, Recognized by Carnegie Classifications
GlobeNewswire
·
April 25, 2025
Newark, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Two of New Jersey Institute of Technology’s most distinguishing qualities — its focus on technology and commitment to access — have been recognized by the Carnegie Classifications. NJIT is among a small and …
Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025
GlobeNewswire
·
April 25, 2025
SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, will announce full year 2024 financial results on Wednesday, April 30, 2025, …
Best Gold IRA Companies of 2025 Announced
GlobeNewswire
·
April 25, 2025
DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Discover the best gold IRA company of 2025 in Gold Investment Planner’s latest rankings. After thorough evaluation, GoldInvestmentPlanner.com has unveiled its newly updated rankings of the Best Gold IRA …
MIXXERS Premium Portable Cocktail Packets for Outdoor Enthusiasts
GlobeNewswire
·
April 25, 2025
Boston, Massachusetts, April 25, 2025 (GLOBE NEWSWIRE) -- MIXXERS, the clear leader in the organic cocktail space just announced something wild: “One of the main problems our customers face is the fact that when they want to chill, whether camping, hiking, …
Oxbridge / SurancePlus to Attend TOKEN2049 Dubai
GlobeNewswire
·
April 25, 2025
GRAND CAYMAN, Cayman Islands, April 25, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized …
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
TEL AVIV, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Bitcoin has skyrocketed recently – SIX MINING provides you with stable passive income
GlobeNewswire
·
April 25, 2025
London, UK, April 25, 2025 (GLOBE NEWSWIRE) -- London, UK Apr 24, 2025 (Copper) Affected by the latest trade policy of US President Donald Trump, the global market is volatile, but cryptocurrencies are rising against the trend - Bitcoin has broken through …
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
GlobeNewswire
·
April 25, 2025
SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …